Molecular sieve SSZ-91

US9802830B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9802830-B2
Application numberUS-201514837071-A
CountryUS
Kind codeB2
Filing dateAug 27, 2015
Priority dateAug 27, 2015
Publication dateOct 31, 2017
Grant dateOct 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A family of new crystalline molecular sieves designated SSZ-91 is disclosed. Molecular sieve SSZ-91 is structurally similar to sieves falling within the ZSM-48 family of molecular sieves, and is characterized as: (1) having a low degree of faulting, (2) a low aspect ratio that inhibits hydrocracking as compared to conventional ZSM-48 materials having an aspect ratio of greater than 8, and (3) is substantially phase pure.

First claim

Opening claim text (preview).

What is claimed is: 1. A molecular sieve belonging to the ZSM-48 family of zeolites, wherein the molecular sieve comprises: a silicon oxide to aluminum oxide mole ratio of 40 to 200, at least 70% polytype 6 of the total ZSM-48 family material present in the product, and an additional EUO framework molecular sieve phase in an amount of between 0 and 3.5 percent by weight of the total product; and wherein the molecular sieve has a morphology characterized as polycrystalline aggregates comprising crystallites collectively having an average aspect ratio of between 1 and 8. 2. The molecular sieve of claim 1 , wherein the molecular sieve has, in its as-synthesized form, an X-ray diffraction pattern substantially as shown in the following Table: 2-Theta d-spacing (nm) Relative Intensity(*) 7.55 ± 0.20 1.170 W 8.71 ± 0.20 1.015 W 12.49 ± 0.20  0.708 W 15.12 ± 0.20  0.586 W 21.18 ± 0.20  0.419 VS 22.82 ± 0.20  0.390 VS 24.62 ± 0.20  0.361 W 26.39 ± 0.20  0.337 W 29.03 ± 0.20  0.307 W 31.33 ± 0.20  0.285 W (*)Relative intensity scale in which the strongest line in the X-ray diffraction pattern is assigned a value of 100, wherein: W = weak (>0 to 20); M = medium (>20 to 40); S = strong (>40 to 60); VS = very strong (>60 to 100). 3. The molecular sieve of claim 1 , wherein the molecular sieve has a silicon oxide to aluminum oxide mole ratio of 70 to 160. 4. The molecular sieve of claim 3 , wherein the molecular sieve comprises at least 80% polytype 6 of the total ZSM-48 family material present in the product. 5. The molecular sieve of claim 3 , wherein the molecular sieve comprises at least 90% polytype 6 of the total ZSM-48 family material present in the product. 6. The molecular sieve of claim 3 , wherein the crystallites collectively have an average aspect ratio of between 1 and 5. 7. The molecular sieve of claim 3 , wherein the crystallites collectively have an average aspect ratio of between 1 and 3. 8. The molecular sieve of claim 3 , wherein the molecular sieve comprises between 0.1 and 2 wt. % EUO framework molecular sieve. 9. The molecular sieve of claim 3 , wherein the molecular sieve comprises between 0.1 and 1 wt. % EUO framework molecular sieve. 10. The molecular sieve of claim 3 , wherein the molecular sieve comprises between 0.1 and 2 wt. % EU-1. 11. The molecular sieve of claim 3 , wherein the molecular sieve comprises between 0.1 and 1 wt. % EU-1. 12. The molecular sieve of claim 1 , wherein the molecular sieve has a silicon oxide to aluminum oxide mole ratio of 80 to 140. 13. The molecular sieve of claim 12 , wherein the molecular sieve comprises at least 80% polytype 6 of the total ZSM-48 family material present in the product. 14. The molecular sieve of claim 12 , wherein the molecular sieve comprises at least 90% polytype 6 of the total ZSM-48 family material present in the product. 15. The molecular sieve of claim 12 , wherein the crystallites collectively have an average aspect ratio of between 1 and 5. 16. The molecular sieve of claim 12 , wherein the crystallites collectively have an average aspect ratio of between 1 and 3. 17. The molecular sieve of claim 12 , wherein the molecular sieve comprises between 0.1 and 2 wt. % EUO framework molecular sieve. 18. The molecular sieve of claim 12 , wherein the molecular sieve comprises between 0.1 and 1 wt. % EUO framework molecular sieve. 19. The molecular sieve of claim 12 , wherein the molecular sieve comprises between 0.1 and 2 wt. % EU-1. 20. The molecular sieve of claim 12 , wherein the molecular sieve comprises between 0.1 and 1 wt. % EU-1. 21. The molecular sieve of claim 1 , wherein the molecular sieve comprises at least 80% polytype 6 of the total ZSM-48 family material present in the product. 22. The molecular sieve of claim 1 , wherein the molecular sieve comprises at least 90% polytype 6 of the total ZSM-48 family material present in the product. 23. The molecular sieve of claim 1 , wherein the crystallites collectively have an average aspect ratio of between 1 and 5. 24. The molecular sieve of claim 1 , wherein the crystallites collectively have an average aspect ratio of between 1 and 3. 25. The molecular sieve of claim 1 , wherein the molecular sieve comprises between 0.1 and 2 wt. % EUO framework molecular sieve. 26. The molecular sieve of claim 1 , wherein the molecular sieve comprises between 0.1 and 1 wt. % EUO framework molecular sieve. 27. A method of preparing the molecular sieve of claim 1 , comprising: (a) preparing a reaction mixture containing: at least one source of silicon, at least one source of aluminum, at least one source of an element selected from Groups 1 and 2 of the Periodic Table, hydroxide ions, hexamethonium cations, and water; and (b) subjecting the reaction mixture to crystallization conditions sufficient to form crystals of the molecular sieve. 28. The method of claim 27 , wherein the molecular sieve is SSZ-91 and has, in its as-synthesized form, the X-ray diffraction pattern substantially as shown in the following Table: 2-Theta d-spacing (nm) Relative Intensity(*) 7.55 ± 0.20 1.170 W 8.71 ± 0.20 1.015 W 12.49 ± 0.20  0.708 W 15.12 ± 0.20  0.586 W 21.18 ± 0.20  0.419 VS 22.82 ± 0.20  0.390 VS

Assignees

Inventors

Classifications

  • Particles characterised by their aspect ratio, i.e. the ratio of sizes in the longest to the shortest dimension · CPC title

  • using at least one organic template directing agent · CPC title

  • C01B39/023Primary

    Preparation of physical mixtures or intergrowth products of zeolites chosen from group C01B39/04 or two or more of groups C01B39/14 - C01B39/48 · CPC title

  • Mixtures of different zeolites · CPC title

  • MTW-type, e.g. ZSM-12, NU-13, TPZ-12 or Theta-3 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9802830B2 cover?
A family of new crystalline molecular sieves designated SSZ-91 is disclosed. Molecular sieve SSZ-91 is structurally similar to sieves falling within the ZSM-48 family of molecular sieves, and is characterized as: (1) having a low degree of faulting, (2) a low aspect ratio that inhibits hydrocracking as compared to conventional ZSM-48 materials having an aspect ratio of greater than 8, and (3) i…
Who is the assignee on this patent?
Chevron Usa Inc
What technology area does this patent fall under?
Primary CPC classification C01B39/023. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).